Anil H. Kadam

Proteogenomics Research Institute for Systems Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Bleomycin mouse model with active-phase pulmonary fibrosis and no acute mortality”.

Bleomycin mouse model with active-phase pulmonary fibrosis and no acute mortality

Research Square (Research Square)(2020)10.21203/rs.2.23139/v1

N/A

0DataRank · unranked

0 citations

Peggy H. Faix, Jan E. Schnitzer, Anil H. Kadam

Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy

PLoS ONE(2022)10.1371/journal.pone.0276462

N/A

0DataRank · unranked

11 citations

Kathirvel Kandasamy, Tim Buss, Brittany Cederstrom, Chun Yang, Sreekanth C. Narayanapillai +8 more

Characterization of acute lung injury in the bleomycin rat model

Physiological Reports(2023)10.14814/phy2.15618

N/A

0DataRank · unranked

27 citations

Jan E. Schnitzer, Anil H. Kadam

Progression of Acute Lung Injury in Intratracheal LPS Rat Model: Efficacy of Fluticasone, Dexamethasone, and Pirfenidone

Pharmacology(2023)10.1159/000534329

N/A

0DataRank · unranked

14 citations

Jan E. Schnitzer, Anil H. Kadam

Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint Analysis

Cells(2024)10.3390/cells13060515

N/A

0DataRank · unranked

11 citations

Jan E. Schnitzer, Anil H. Kadam